|
Circadian rhythms are governed by a series of regulatory oscillators expressed
in the suprachiasmatic nucleus (SCN), and elsewhere in the CNS as well as in
most peripheral tissues, that oscillate with an approximate 24-hour periodicity
usually entrained to the light-dark cycle.1 In mice, Clock (Circadian
Locomotor Output Cycles Kaput - OMIM 601851) encodes an 855 aa transcription
factor involved in this process. Overexpression of Clock shortens
period length. Expression of an A to T nucleotide transversion in a splice
donor site that leads to exon skipping and deletion of 51 aa results in 1-hour
lengthening of locomotor activity in the heterozygous state and 3- to 4-hour
increase in periodicity and dampening of the amplitude of circadian rhythms,
leading to loss of periodicity (arrhythmia) in the homozygous animal maintained
in constant darkness. Stimulated by the observation that reduced forms of the
nicotinamide adenine dinucleotide (NAD) cofactors enhance, and oxidized forms
inhibit, DNA binding of the Clock transcript, Turek et al investigated
the relationship between circadian rhythmicity and intermediary metabolism
in homozygous Clock mutant mice (C-/-) maintained on a 12-hour light-dark
cycle. They demonstrated that relative to wild-type (WT) mice, the C-/- mice
had decreased locomotor activity during darkness. Also, the C-/- animals ate
rather evenly through the 24-hour period, whereas the WT mouse ate 3-fold more
during darkness than during light. In addition, the C-/- mice expended 10%
less energy per 24 hours than did the WT animals. C-/- animals were heavier
than WT animals by 6 weeks of age; between 6-16 weeks of age,
C-/- mice ate greater amounts of food and gained more weight than did WT mice,
whether ingesting a normal or high-fat diet. At 7 to 8 months of age, C-/- animals
had higher concentrations of leptin, glucose, cholesterol, and triglycerides
than did WT mice, but they had similar levels of insulin. Histologically, there
were hypertrophy of adipocytes and excessive glycogen and lipid within liver
cells (steatosis) in C-/- animals. In the mediobasal hypothalamus, the diurnal
patterns of expression (mRNA levels) of orexin and ghrelin (orexigenic agents)
and of CART (cocaine- and amphetamine-regulated transcript—an anorexigenic
agent) were decreased in C-/- mice relative to WT animals. The authors concluded
that Clock and the circadian rhythms it controls have regulatory effects
on energy intake and expenditure and fuel metabolism. When altered, the resultant
abnormalities lead to a syndrome of obesity, hyperglycemia, and hyperlipidemia
that mimics the metabolic syndrome and that might be mediated through hypothalamic
pathways that regulate appetite and energy utilization.
Turek FW, Joshu C, Kohsaka A, et al. Obesity and metabolic syndrome in circadian Clock mutant mice. Science. 2005;308:1043–1045.
Editor’s Comment: Circadian rhythms are present not
only in neurons within the SCN but also in single cells in most peripheral
tissues and utilize the same regulatory mechanisms found in the SCN.2 Thus,
it is likely that the SCN synchronizes overall diurnal rhythms, while local
oscillators regulate tissue-specific circadian function. It is unclear whether
the metabolic effects of the described loss-of-function mutation in Clock are
exerted through the SCN or in peripheral tissues, but the results of loss of
diurnal variability on lipid and carbohydrate metabolism are striking. In volunteer
human males, sleep deprivation lowered leptin and increased ghrelin values
leading to increase in hunger and appetite.3 Future studies evaluating the
role of the sleep-wake cycle on intermediary metabolism and the genesis of
the metabolic syndrome in man are clearly warranted.
Allen W. Root, MD
References - (linked to )
- Rivkees S. Growth Genet Hormon. 2002;18:1–6.
- Block G. Sci Aging Knowl Environ. 2005;19:pe13.
- Spiegel K, Tasali E, Penev P, Van Cauter E. Ann Intern Med. 2004;141:846–850.
|